BECN1 and type 2 diabetes mellitus: Therefore, targeting of these signaling mainly Beclin‐1, mTOR, calpain, PI3K, cAMP, HDAC6, and Ca2 by specific modulators could be an effective therapeutic strategy in the management of T2D.